Clinical Trial: Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TRT-448 in Healthy Adult Subjects

U.S., Aug. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07745751) titled 'Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TRT-448 in Healthy Adult Subjects' on July 28.

Brief Summary: Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TRT-448 in Healthy Adult Subjects

Study Start Date: Aug. 30

Study Type: INTERVENTIONAL

Condition: Safety and Tolerability in Healthy Volunteers

Intervention: DRUG: TRT-448

Investigational drug modulates immune cells for the treatment of inflammatory disease

DRUG: Placebo

Inert placebo utiliz...